Guggenheim Capital’s ChemoCentryx, Inc. CCXI Stock Holding History

Guggenheim Capital’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-36,026	Closed	-$1.86M	–	2038
2022 Q3	$1.86M	Sell	36,026 -6,710	-16%	-$277K	0.02%	869
2022 Q2	$1.06M	Sell	42,736 -3,150	-7%	-$69.4K	0.01%	1193
2022 Q1	$1.15M	Buy	45,886 +5,529	+14%	+$155K	0.01%	1291
2021 Q4	$1.47M	Sell	40,357 -17,224	-30%	-$605K	0.01%	1202
2021 Q3	$985K	Sell	57,581 -8,161	-12%	-$127K	0.01%	1426
2021 Q2	$880K	Buy	65,742 +31,776	+94%	+$783K	0.01%	1556
2021 Q1	$1.74M	Sell	33,966 -86	-0.3%	-$5.17K	0.01%	1105
2020 Q4	$2.11M	Buy	+34,052	New	+$1.95M	0.01%	944

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Guggenheim Capital's CCXI Position: Q4 2022 in Review

Guggenheim Capital sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 36,026 shares — an estimated $1.86M sold.

Guggenheim Capital first reported a position in CCXI in Q4 2020 and held it in 8 quarters. The position peaked at $2.11M in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Guggenheim Capital reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Guggenheim Capital sold 36,026 ChemoCentryx, Inc. shares in Q4 2022, an estimated $1.86M.
Guggenheim Capital first reported a position in ChemoCentryx, Inc. in Q4 2020 and held it in 8 quarters.
Guggenheim Capital's ChemoCentryx, Inc. position peaked at $2.11M in Q4 2020.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Guggenheim Capital's 13F filing for Q4 2022, filed 14 Feb 2023.